Results

Total Results: 1,426 records

Showing results for "stage".

1101. Chronic-urinary-retention-protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
      November 19, 2012 - At this stage we plan to include all interventions identified in the literature. … At completion of this stage, we will consult with our TEP to ensure that we capture only studies examining

1102. Methods Research Report - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
      April 01, 2013 - paradigms that allow for multiple rounds of drug treatment (first-, second-, third-, and even fourth-stage … showed increases in median duration from as low as 0.7 weeks (8 vs. 7.3 weeks;64 patients with end stage … Study characteristics Author, Year Cancer Type Cancer Stage Experimental Drug vs. … Role of sensitivity analyses in assessing progression-free survival in late-stage oncology trials. … The value of progression-free survival to patients with advanced-stage cancer.

1103. Stroke Prevention in Atrial Fibrillation Patients: A Systematic Review Update | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/stroke-afib-update/research-protocol
      July 07, 2017 - thrombin inhibitor; DVT = deep vein thrombosis; eGFR = estimated glomerular filtration rate; ESRD = end-stage … At the full-text screening stage, two independent reviewers must agree on a final inclusion/exclusion … thrombosis eGFR = estimate glomerular filtration rate EPC = Evidence-based Practice Center ESRD = end-stage … "cardiac diseases"[tiab] OR "chronic kidney failure"[tiab] OR "chronic renal failure"[tiab] OR "end stage … renal disease"[tiab] OR ESRD[tiab] OR “end stage kidney disease”[tiab] OR ESKD[tiab] OR “renal function

1104. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
      November 01, 2010 - steps of study • patient characteristics, including: o age o sex o race/ethnicity o disease and stage … OR "Neoplasm Recurrence, Local"[Mesh])) OR "secondary "[Subheading] OR recurrent OR recurrence OR (stage … OR "Neoplasm Recurrence, Local"[Mesh])) OR "secondary "[Subheading] OR recurrent OR recurrence OR (stage … OR "Neoplasm Recurrence, Local"[Mesh])) OR "secondary "[Subheading] OR recurrent OR recurrence OR (stage … OR "Neoplasm Recurrence, Local"[Mesh])) OR "secondary "[Subheading] OR recurrent OR recurrence OR (stage

1105. Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
      April 25, 2013 - duration, escalation), Hb (baseline, and all recorded values preferably at times specified by protocol), stage … considering the risks-benefits of ESA therapy in the context of a specific patient, with a specific type and stage … Page 100, line 56, 57: inserted text ‘by’ Page 101, line 18: inserted text ‘stage of malignancy, treatment … The BEST study enrolled patients with similar tumor type and stage, but allowed any chemotherapy regimen … Untch et al (n = 729), respectively, both enrolled a patient population with similar tumor type and stage

1106. S5 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
      October 01, 2007 - methods, patient safety, pharmaceuticals, research, statistics (Med Care 2007;45: S5–S8) SETTING THE STAGE

1107. Colorectal-Cancer-Liver-Metastases-Therapies Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
      December 01, 2012 - Treatment of Colorectal Cancer The diagnosis of CRC requires pathologic review to characterize and stage … I, 64.5 percent for stage IIA, 51.6 percent for stage IIB, 32.3 percent for stage IIC, 74 percent for … IIIA, 45 percent for IIIB, 33.4 percent for IIIC, and 6 percent for stage IV.9 Survival declines … with increasing depth of tumor penetration, increasing tumor stage, and patient age. … Patients with stage III colon cancer who received postsurgical FOLFOX chemotherapy had a 3-year survival

1108. Menopause-Protocol-130612 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
      June 12, 2013 - Source: www.effectivehealthcare.ahrq.gov Published online: June 12, 2013 Evidence-based Practice Center Systematic Review Protocol Project Title: Menopausal Symptoms: Comparative Effectiveness Review of Therapies Original  Date  of  Protocol:  April  3,  2012   Amendment  Date:  June  5, …

1109. Topic Suggestion Description | Effective Health Care Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-in-the-postpartum-period-what-is-the-effectiveness-and-safety-of-screening-and-treatment-for-depression-please-use-the-uspstf-framework-which-considers-not-only-screening-but-followup-treatment-and-management-the-tr
      October 01, 2011 - (For example, an ethnic group, stage or severity of a disease.)

1110. Lung Cancer Screening With Low-DoseComputed Tomography (LDCT) (pdf file)
      effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-clin-summary.pdf
      March 01, 2016 - detection and treatment is ideal, only 15 percent of lung cancer cases are diagnosed at an early stage

1111. Topic Suggestion Description | Effective Health Care Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/measurement-and-outcomes-need-consensus-definitions-state-medicaid-programs-need-robust-hedis-and-ncqa-measures-for-all-severe-and-persistent-mental-health-conditions-consensus-definitions-would-help-answer-questions-such-as-
      November 23, 2010 - (For example, an ethnic group, stage or severity of a disease.)

1112. Lung Cancer Screening With Low-DoseComputed Tomography (LDCT) (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-clin-summary.pdf
      March 01, 2016 - detection and treatment is ideal, only 15 percent of lung cancer cases are diagnosed at an early stage

1113. Topic Suggestion Description | Effective Health Care Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/the-american-college-of-chest-physicians-accp-proposes-to-update-the-following-4-guideline-topics-from-the-2006-publication-on-the-diagnosis-and-management-of-cough-accp-evidence-based-clinical-practice-guidelines1-1-assessin
      January 01, 2006 - (For example, an ethnic group, stage or severity of a disease.)

1114. Disposition of Comments Report for Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
      October 01, 2014 - It is refreshing to see concerns of patient anxiety and quality of life sharing the stage with the … That is, changes in therapeutic management or stage reclassification are appropriate terminal points

1115. Use of Observational Studies in Systematic Reviews of (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
      June 01, 2010 - consultation with clinical experts may also identify important gaps in the RCT evidence at the protocol stage … registry in the United States that enrolls patients who have received ventricular assist devices for end-stage … Well-known or large RCTs should be examined in detail at this stage.

1116. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
      May 01, 2012 - Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and … Hoskin, 201219 -- n = 218 EBRT: n = 108 EBRT + high- dose-rate brachytherapy boost: n = 110 Stage … Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and

1117. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
      May 01, 2012 - Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and … Hoskin, 201219 -- n = 218 EBRT: n = 108 EBRT + high- dose-rate brachytherapy boost: n = 110 Stage … Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and

1118. Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension – An Update of the 2007 Report | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research-protocol
      May 07, 2010 - failure, cerebral vascular disease or events [including stroke], symptomatic coronary artery disease, end-stage … the current search strategy and initial number of abstracts to be included in our abstract screening stage

1119. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/cancer-quality-indicator-testing/research
      May 19, 2010 - the cancer registry to identify patients diagnosed in 2006 with one of the following tumor types and stage … At JHH/SKCCC, the cancer registry identified patients with stage IV lung, pancreatic, breast, and colorectal … cancer (and Stage IIIB for lung cancer) disease in 2003-2005 who died 2-15 months after diagnosis.

1120. Gout-managment-protocol-141103 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
      November 03, 2014 - Therefore primary care physicians (PCPs) and emergency physicians are well-positioned to diagnose early-stage … Full-text articles will be dually reviewed; disagreements regarding inclusion at the full-text stage … comorbidities, we will determine whether studies report factors such as sex, duration of the condition, and stage